may shortly become the primary treatment of choice for patients with chronic hepatitis B.

Functional cure, defined as durable hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA titers below the ...

Liver fibrosis is a key process in the progression of chronic liver diseases. However, there are currently no drugs ...

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol 67, 370–98 (2017). 9. Terrault NA. et al., Update on Prevention, Diagnosis, and Treatment of ...

These findings promise new hope for patients undergoing long-term antiviral treatment for hepatitis B. Reference: Yim HJ, Seo YS, Kim JH, et al. Switching to besifovir in patients with chronic ...

SEOUL, South Korea, April 9, 2025 /PRNewswire/ -- Chronic hepatitis B (CHB) is currently estimated ... most widely used antiviral agent for CHB treatment. However, long-term use of TDF has adverse ...

or factors independent of hepatitis B. Whether HBeAg-negative hepatitis caused by mutations in the core promoter and/or precore region occur more frequently in IFN- or lamivudine-treated ...